CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 3/A Insider 3/A
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 25-NSE Other Notification of Removal from Listing
- 4 Open-market buy Chairman and CEO bought 16,500 shares at $2.98 ($49,170)
- 4 Open-market buy Vice Chairman & COO bought 1,800 shares at an average $2.94 ($5,284)
- 4 Open-market buy Chairman and CEO bought 5,500 shares at an average $2.69 ($14,815)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Auditor change
- 4 Open-market buy Chairman and CEO bought 7,000 shares at $2.78 ($19,460)
- 4 Open-market buy Vice Chairman & COO bought 7,890 shares at an average $2.65 ($20,893)
- 4 Open-market buy Chairman and CEO bought 6,500 shares at $2.72 ($17,680)
- 4 Open-market buy Chairman and CEO bought 19,100 shares at an average $2.58 ($49,370)
- 4 Open-market buy Vice Chairman & COO bought 11,000 shares at an average $2.61 ($28,710)
- 8-K Event Other events
- 3/A Insider 3/A
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy Chairman and CEO bought 10,000 shares at an average $2.13 ($21,300)
Page 16 of 63 · 1,250 filings